Depression Treatment Bundle

Featuring content from our annual Psychiatric Pharmacotherapy Update

About

The sessions in this course bundle were recorded during the 2022 and 2023 Psychiatric Pharmacotherapy Updates. They have been optimized for on-demand viewing and grouped together for your convenience.

Learning Objectives

Learning Objectives for each of the three sessions are located in the session tabs below.

A Note About CPE Credit

Please note that if you have taken any of the courses in this bundle before, you will not be able to claim credit for the course again. The CPE monitor will only allow one credit to be claimed per UAN, meaning that credit can only be claimed once, even if you watch the video multiple times.

Instructions

This program consists of one video and downloadable resources in PDF format.

To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date.

Speaker information and disclosures can be found in the tabs below.

Fee

$30.00

CE Hours

3.00

CE Units

0.300

Activity Type

Knowledge

Support/Credits

Continuing Education Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.30 CEUs (3.00 contact hours) of continuing education credit. To receive 3.00 contact hours of CE credit, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days).

Update on Treatment-Resistant Depression in Adults

Update on Treatment-Resistant Depression in Adults

Learning Objectives

Review expert consensus on TRD definition and placement of new therapies in treatment algorithms
Discuss new treatments in development impacting Glutamate/GABA neurophysiology
Discuss relevant differences between TMS treatment protocols that inform their use in TRD patients

About the Speakers

Marisa S. P. Toups, M.D.
Psychiatrist/Owner, Singularity Psychiatry and Mental Health
Affiliate Assistant Professor
UT Southwestern Medical School Department of Psychiatry

Dr. Toups is a board-certified psychiatrist and specialist in treatment-resistant depression. After medical school, she completed psychiatric training, including a specialty fellowship focusing on the study of treatment outcomes for Major Depressive Disorder, at UT Southwestern Medical Center in Dallas, TX. As faculty at UT Southwestern and UT Austin Dell Medical School, she studied the role of immunity in major depression and served as an investigator in numerous clinical trials. She has taught evidence-based medicine to psychiatry residents, is the co-author of an award-winning journal club curriculum, and co-hosts a related podcast, the Yeah, No Journal Club. She now runs her practice, Singularity Psychiatry and Mental Health, where she provides expert psychiatric care for patients with complex depression.

Disclosure: Dr. Toups has no financial relationship(s) to disclose.

Nicholas Ortiz, M.D.
Assistant Professor of Psychiatry
The University of Texas at Austin Dell Medical School

Nicholas Ortiz, M.D., is a board-certified psychiatrist at UT Health Austin’s Mulva Clinic for the Neurosciences. Additionally, Dr. Ortiz is an assistant professor in the Dell Medical School Department of Psychiatry. He serves on the Medical Executive Council for Ascension Seton Shoal Creek and as the Clinical Director of Electroconvulsive Therapy (ECT) for Ascension Seton Medical Center. Dr. Ortiz is also the clinical director of Transcranial Magnetic Stimulation (TMS) for UT Health Austin. Dr. Ortiz completed a residency in psychiatry at The University of Texas at Austin Dell Medical School. He received his medical degree from The University of Texas Health Science Center San Antonio and earned his bachelor’s in science from Southwestern University. Dr. Ortiz’s clinical interests include Neurostimulation, Major Depressive Disorder, Bipolar Disorder, and inpatient psychiatry. He is a prolific instructor at Dell Med and also participates in research and publications.

Disclosure: Dr. Ortiz has no financial relationship(s) to disclose.

Activity Number

0067-0000-22-124-H01-P

Release Date: Oct 14, 2022

Credit Expiration Date: Oct 13, 2025

CE Hours

1.00

Psychopharmacology Myth-Busting: A Focus on Antidepressants

Psychopharmacology Myth-Busting: A Focus on Antidepressants

Learning Objectives

Compare commonly believed medication adverse effect myths to the facts from the literature.
Evaluate the evidence of common efficacy myths heard in practice to the facts from the literature.
Determine if common clinical myths in psychopharmacology are evidence-based.

About the Speakers

Tawny Smith, Pharm.D., BCPP

Associate Professor of Psychiatry

The University of Texas at Austin Dell Medical School

After graduating with her Pharm.D. degree, Dr. Smith completed a psychiatric pharmacy residency and clinical sciences fellowship in mental health outcomes at The University of Texas at Austin College of Pharmacy. She is a board-certified psychiatric pharmacist currently serving as an Associate Professor of Psychiatry and Behavioral Sciences for The University of Texas at Austin (UT), Dell Medical School. She also maintains an adjunct faculty appointment with the UT College of Pharmacy. She has outpatient practices at UT Health Austin Women's Reproductive Mental Health and Bipolar clinics and serves as a consultant for the Perinatal Psychiatry Access Network (PeriPAN). She is also the director of the psychopharmacology consult service at Ascension Seton Shoal Creek. She serves as one of the core faculty for the DMS psychiatry residency program where she has been awarded several teaching awards. She has delivered numerous educational presentations to the community and other health professionals at national and international conferences throughout her career. She has over 85 published abstracts, peer-reviewed articles and book chapters in the area of psychiatric pharmacy. She is an active member of the American Association for Psychiatric Pharmacists (AAPP) and is currently the chair for the Continuing Professional Development committee. She remains active in her community and serves on the Board of Directors for both the Austin Clubhouse, as well as the Hill Country chapter of the National Charity League.

Disclosure: Dr. Tawny Smith does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Marisa S.P. Toups, M.D.

Psychiatrist/Owner, Singularity Psychiatry and Mental Health

Affiliate Assistant Professor
UT Southwestern Medical School Department of Psychiatry

Dr. Toups is a board-certified psychiatrist and specialist in treatment-resistant depression. After medical school, she completed psychiatric training, including a specialty fellowship focusing on the study of treatment outcomes for Major Depressive Disorder, at UT Southwestern Medical Center in Dallas, TX. As a faculty member at UT Southwestern and UT Austin Dell Medical School, she studied the role of immunity in major depression, as well as served as an investigator in numerous clinical trials. She is active in teaching evidence-based medicine, is the co-author of an award-winning journal club curriculum, Journal Club Super Star, and co-hosts a related podcast, the Yeah, No Journal Club. She now runs her own practice, Singularity Psychiatry and Mental Health, where she provides expert psychiatric care for patients with complex depression.

Disclosure: Dr. Marisa Toups does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-23-160-H04-P/T

Release Date: Oct 26, 2023

Credit Expiration Date: Oct 25, 2026

CE Hours

1.00

Pediatric Depression Update

Pediatric Depression Update

Learning Objectives

Discuss the epidemiology of depression in youth, including issues with diverse populations.
Summarize the evidence for the pharmacotherapy of depression in youth, including new approaches to treatment.
Interpret the boxed warning for antidepressants in youth and place it into perspective for the clinician.

About the Speaker

M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP

Professor of Pharmacy & Psychiatry

The University of Texas at Austin

M. Lynn Crismon is a Professor of Pharmacy and Psychiatry at The University of Texas at Austin. He is the former Behrens Centennial Professor of Pharmacy and past Dean and James T. Doluisio Regents Chair of the College of Pharmacy. He is board-certified in psychiatric pharmacy and a Diplomate of the American Board of Clinical Pharmacology. His research has focused on improving the pharmacotherapy of severe mental disorders and mental health outcomes research. He has over 270 publications and 210 abstracts. Since 2004, he has co-led the development and the updating of the Psychotropic medication utilization parameters for children and youth in Texas Public Behavioral Health. He is a founding steering committee member, faculty member, and coach in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care Mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being, which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives.

Disclosure: Dr. M. Lynn Crismon does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).

Activity Number

0067-0000-23-172-H05-P/T

Release Date: Oct 27, 2023

Credit Expiration Date: Oct 26, 2026

CE Hours

1.00